Bayer AG is consolidating its United States glyphosate business into its newly formed Ruveon subsidiary, marking a significant step in the restructuring of its agricultural operations.
The move follows the company's request to Washington for duties on Chinese imports of the chemical, a key ingredient in its Roundup weedkiller.
Handelsavisen previously reported that Bayer is accelerating efforts to conclude its global settlement with plaintiffs alleging cancer links to Roundup.
The consolidation into Ruveon isolates the US herbicide segment, allowing Bayer to manage the business separately from its broader agricultural portfolio.
This structural change comes as the company seeks to mitigate supply chain risks and trade exposure by lobbying for protective tariffs against Chinese competitors.
Handelsavisen previously reported that Bayer is accelerating efforts to conclude its global settlement with plaintiffs alleging cancer links to Roundup.
The spin-off of the US glyphosate business into Ruveon appears to be part of a broader strategy to ring-fence liabilities and operational risks associated with the controversial herbicide.